Statistics for Lava Therapeutics B.V. (id:8429 LVTX)
Valuation metrics
Market cap
31.82M
Enterprise value
-30,409,114.00
Trailing P/E (ttm)
3.00
Forward P/E
3.00
PEG ratio
3.00
Price/Sales (ttm)
4.30
Price/Book (mrq)
3.00
Enterprise Value/Revenue
-4.11
Enterprise Value/EBITDA
1.13
Overview
Shares outstanding
26.30M
Float
12.09M
Shares short
26.44K
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
213.27K
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
6.47
52-Week change
-45.63%
Beta
3.00
50-Day moving average
1.70
200-Day moving average
2.17
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
48.56%
Operating margin
-371.48%
Operational effectiveness
Return on assets
-15.99%
Return on equity
-45.30%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
3.29M
EBITDA
-26,883,000.00
Net income to common (ttm)
-24,183,000.00
Diluted EPS (ttm)
-1.01
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
86.80M
Total cash per share (mrq)
3.30
Total debt (mrq)
6.16M
Total Debt/Equity (mrq)
14.37
Current ratio (mrq)
639.00%
Book value per share (mrq)
1.95
Cash flow
Cash flow statement
-27,081,000.00
Levered free cash flow (LFCF)
-17,983,250.00